#nervgen
Latest news and interesting information about nervgen.
NervGen stock slumps on dilutive offering
NervGen Pharma shares plummet 39.7% after dilutive share offering. Expected proceeds of $60 million.
NervGen Prices $60M Offering at $2.50/Share
NervGen Pharma prices $60M public offering of 24 million shares at $2.50 each. Proceeds to fund NVG-291 clinical trials and corporate needs.
...